Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4279375)

Published in Oncotarget on November 15, 2014

Authors

Ezra Ella1, Denise Heim2, Evgeniy Stoyanov1, Rona Harari-Steinfeld1, Israel Steinfeld3, Orit Pappo4, Temima Schnitzer Perlman1, Natalie Nachmansson5, Ludmila Rivkin1, Devorah Olam1, Rinat Abramovitch6, Henning Wege2, Eithan Galun1, Daniel Goldenberg1

Author Affiliations

1: The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
2: Department of Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
3: Computer Science Department, Technion-Israel Institute of Technology, Haifa, Israel.
4: Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
5: Magnetic Resonance Imaging/Magnetic Resonance Spectroscopy Laboratory, Human Biology Research Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
6: The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Magnetic Resonance Imaging/Magnetic Resonance Spectroscopy Laboratory, Human Biology Research Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Articles cited by this

Hepatocellular carcinoma. Lancet (2012) 18.09

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 7.55

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 7.16

Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res (2002) 5.99

The causes and consequences of genetic heterogeneity in cancer evolution. Nature (2013) 5.91

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell (2006) 4.33

The H19 non-coding RNA is essential for human tumor growth. PLoS One (2007) 3.75

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci U S A (2012) 2.85

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66

Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol (1994) 2.26

The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays (2010) 2.23

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology (2013) 2.13

Loss of DNA replication control is a potent inducer of gene amplification. Science (2010) 2.02

The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A (2008) 1.98

Spontaneous lesions in aging FVB/N mice. Toxicol Pathol (1997) 1.61

Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp Cell Res (2002) 1.48

Centromere mitotic recombination in mammalian cells. J Cell Biol (2008) 1.35

Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A (2010) 1.26

Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res (2011) 1.15

Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency. Nat Commun (2014) 1.02

Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Mol Cancer Res (2007) 0.99

Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. Mol Cancer Res (2011) 0.96

Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice. Carcinogenesis (1990) 0.94

CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver. Biochem Biophys Res Commun (2008) 0.89

cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med (2013) 0.89

ICER expression inhibits leukemia phenotype and controls tumor progression. Leukemia (2008) 0.88

Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis. Hepatology (2013) 0.86

Autosomal telomere exchange results in the rapid amplification and dispersion of Csf2ra genes in wild-derived mice. Mamm Genome (2001) 0.81

Coamplification and cooperation: toward identifying biologically relevant oncogenes. Clin Cancer Res (2013) 0.81

Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature. Mol Ther (2013) 0.79

Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. Thyroid (2012) 0.78

Inducible cAMP early repressor regulates the Period 1 gene of the hepatic and adrenal clocks. J Biol Chem (2013) 0.78